Science Explorer Interactive view Map
Company · Warren · United States

Bellerophon Therapeutics (United States)

bellerophon.comROR OpenAlex
Research works
4
▲ 43% vs 2013–17
Citations
62
16.2 per fractional work
Top-10% rate
15.6%
record average 16.5%
Open access
44%
world 28%

Not ranked overall: Bellerophon Therapeutics (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which research topics does Bellerophon Therapeutics (United States) publish most on?

By volume in 2022–2025: Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis, Pulmonary Hypertension Research and Treatments, Sarcoidosis and Beryllium Toxicity Research and Medical Imaging and Pathology Studies.

Interstitial Lung Diseas…0Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis: 0 fractional worksPulmonary Hypertension Research and Treatments: 0 fractional worksSarcoidosis and Beryllium Toxicity Research: 0 fractional worksMedical Imaging and Pathology Studies: 0 fractional worksChronic Obstructive Pulmonary Disease (COPD) Research: 0 fractional works
Pulmonary and Respiratory MedicinePhysiology

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis Pulmonary and Respiratory Medicine 0 works
  2. 2 Pulmonary Hypertension Research and Treatments Pulmonary and Respiratory Medicine 0 works
  3. 3 Sarcoidosis and Beryllium Toxicity Research Physiology 0 works
  4. 4 Medical Imaging and Pathology Studies Pulmonary and Respiratory Medicine 0 works
  5. 5 Chronic Obstructive Pulmonary Disease (COPD) Research Pulmonary and Respiratory Medicine 0 works
  6. 6 Phosphodiesterase function and regulation Molecular Biology 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available43.8%not open56.2%

World: 28% of research is openly available.

with international co-authors61.9%domestic only38.1%

World: 19% is written across borders.

How has Bellerophon Therapeutics (United States)'s research output changed?

Output in 2018–2022 was 43% higher than in 2013–2017.

2020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Warren

All research institutions in Warren

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.